Medifast (MED) Tops Q3 EPS by 105c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $11.87 -2.47%
Revenue Growth %: -24.3%
Financial Fact:
Income from operations: 8.95M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Revenue Growth %: -24.3%
Financial Fact:
Income from operations: 8.95M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q3 EPS of $2.12, $1.05 better than the analyst estimate of $1.07. Revenue for the quarter came in at $235.9 million versus the consensus estimate of $232.1 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- RBC Capital Reiterates Outperform Rating on Verisk Analytics (VRSK)
- Goldman Sachs sees US stocks dip on tech earnings and macro shifts
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
